EU and US could reach trade deal this weekend - Reuters
On Friday, Cantor Fitzgerald reaffirmed its Overweight rating on 3D Systems (NYSE:DDD), with a steady price target of $5.00, representing significant upside from the current price of $2.15. According to InvestingPro data, the stock appears undervalued based on its Fair Value analysis, despite facing recent challenges. The firm’s analysis highlighted 3D Systems’ increased sales of new industrial printer systems and global services in the fourth quarter of 2024, as well as a resurgence in consumable sales across most markets. Despite these positive trends, an accounting adjustment in the company’s Regenerative Medicine program impacted the financials, resulting in a $8.7 million reduction in Healthcare Solutions revenue.
3D Systems reported total revenue of $111.0 million, contributing to trailing twelve-month revenue of $440.12 million, marking a concerning 9.82% decline year-over-year. The quarterly results came in approximately 4% below both Cantor Fitzgerald and FactSet consensus estimates. Specifically, the Healthcare Solutions segment saw a 21% decrease in revenue to $40.4 million. In contrast, revenue from the Industrial Solutions sector showed an 11% year-over-year increase, reaching $70.7 million. InvestingPro analysis reveals the company maintains a strong current ratio of 3.08, indicating solid short-term liquidity despite operational challenges.
The company’s non-GAAP earnings per share (EPS) for the quarter was reported at $(0.19), which did not meet the $(0.12) projection by Cantor Fitzgerald nor the $(0.11) consensus among FactSet analysts. Following the earnings report, 3D Systems’ shares experienced a significant drop of roughly 21%, underperforming when compared to the stable results of the S&P 500 and Russell 2000 indices.
Cantor Fitzgerald’s reiterated Overweight rating is based on a valuation that applies an enterprise value to sales (EV/Sales) multiple of 1.5x, which remains unchanged. This valuation is projected from a 2026 sales assumption of $455.0 million for 3D Systems. Despite the recent decline in share value and moderate debt levels with a debt-to-equity ratio of 1.56, the research firm continues to express confidence in the stock’s potential, maintaining the same price target and rating. Discover more detailed valuation metrics and comprehensive analysis through InvestingPro’s extensive financial research platform.
In other recent news, 3D Systems Corporation reported its fourth-quarter and full-year 2024 earnings, showing a greater-than-expected loss and a decline in revenue. The company’s earnings per share for Q4 2024 were -$0.19, missing the forecast of -$0.10, and revenues came in at $111 million against the expected $115.6 million. Full-year consolidated revenues dropped 10% year-over-year to $440 million. The company is focusing on cost reduction and operational efficiency to address these challenges. Analysts from Needham and Company and Cantor Fitzgerald have shown interest in the company’s strategy, particularly in its industrial and dental markets. In terms of future guidance, 3D Systems projects 2025 revenues between $420 million and $435 million, with plans to achieve breakeven or better adjusted EBITDA by the fourth quarter of 2025. The company also announced cost reduction and restructuring actions targeting over $50 million in annualized savings, which are expected to improve gross margins and reduce operating expenses.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.